文献速递肾小球疾病肾移植

早期原发性FSGS复发后供肾成功再移植一例

Successful Reuse of Kidney Graft After Early Recurrence of Primary Focal and Segmental Glomerulosclerosis.
PubMed 文献 · Am J Kidney Dis · 2021-06-09

本文报告一例23岁男性因原发性FSGS复发且对多种治疗无效,在移植后8个月将移植肾摘除并再植入一名78岁无免疫史无肾患者体内。再移植后即刻恢复肾功能,蛋白尿逐步缓解,1年后血肌酐1.2mg/dL、蛋白尿0.1g/d,活检仍见FSGS病变但足突融合减轻。

要点

  • 对多种治疗无效的早期原发性FSGS复发,移植肾摘除后再移植或为可行选择
  • 再移植后受者肾功能即刻恢复,蛋白尿逐步缓解
  • 再移植肾活检仍见FSGS病变,但足突融合程度减轻

核心结论

  • 早期原发性FSGS复发且对现有治疗均无效时,移植肾摘除后再植入另一受者仍可能可行,这是首次报道的此类病例。

研究设计与样本

  • 病例报告:1例23岁男性原发FSGS受者移植后早期复发,经4线治疗无效,8个月后摘除移植肾并再植入1例78岁无免疫史、双侧肾切除的无肾受者。

主要发现

  • 患者1移植后立即出现活检证实的原发性FSGS复发,经静脉环孢素联合糖皮质激素、血浆置换、免疫吸附和利妥昔单抗4线治疗后仍处高度肾病状态且肾功能缓慢恶化。
  • 再移植后患者2即刻恢复肾功能,蛋白尿逐步缓解,1年后血肌酐1.2mg/dL、蛋白尿0.1g/d。
  • 术后活检显示持续性FSGS病变,但整体足突融合减少。

临床怎么用

  • 对早期原发性FSGS复发且所有可用治疗均无效者,在患者与卫生主管部门批准下,可考虑将移植肾摘除后再移植给其他受者。

局限性

  • 为单例病例报告,结论外推需谨慎;随访仅1年,长期结局未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary focal and segmental glomerulosclerosis (FSGS) frequently recurs after transplantation and is associated with a poor prognosis. We describe here the successful kidney graft reuse in an adult recipient, 8 months after early primary FSGS recurrence resistant to all available therapeutics. Patient 1, a 23-year-old man, followed for kidney failure secondary to primary FSGS, was first transplanted in 2018 with a deceased donor graft. Unfortunately, we observed an immediate recurrence of biopsy-proven primary FSGS. After 4 lines of treatment (intravenous cyclosporine+corticosteroids, plasma exchanges, immunoadsorption, and rituximab), the patient was still highly nephrotic and kidney function was slowly deteriorating. After approval from both the patient and the health authority (Biomedicine Agency), the graft was detransplanted 8 months after transplantation and reimplanted in patient 2, a 78-year-old nonimmunized and anephric recipient (bi-nephrectomy 2 years previously for bilateral renal carcinoma). We observed immediate kidney function and progressive resolution of proteinuria (serum creatinine of 1.2mg/dL and proteinuria of 0.1 g/d 1 year later). Biopsies performed after surgery showed persistent FSGS lesions with a decrease in overall foot-process effacement. To our knowledge, this is the first reported case showing that kidney graft transfer may still be a viable option for refractory primary FSGS several months after transplantation.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Hamroun A, Gibier JB, Maanaoui M, et al. Successful Reuse of Kidney Graft After Early Recurrence of Primary Focal and Segmental Glomerulosclerosis. Am J Kidney Dis. 2021. PMID: 34118304. doi:10.1053/j.ajkd.2021.03.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。